DFX Intelligence

Michael Steinmetz

Role unknown· MA

As of 2026-09-12 · this person's identity; each section below carries its own date

Current roles: 0
Investments attributed: 7
Board seats: 2

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-12 · this person's identity; each section below carries its own date

4 additional attributed investments

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Nothing material in the last 365 days.

Relationship network

3 connected entities7 observed investment recordsinvestment records 2010 to 2013

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Michael Steinmetz

Reading the network

Organization
Company

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Michael Steinmetz connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Michael Steinmetz: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Michael Steinmetz

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

0 current, 1 past

Clarus Ventures, LLC Managing Director
Jan 1, 2005 to Mar 24, 2017 · “Listed on Schedule A of filing 2016-03-21 as MANAGING DIRECTOR, absent from filing 2017-03-24”
Inference Form ADV

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Allozyne Inc	Form D equity offering · $900,000	Clarus Ventures, LLC	strongly supported · board	Apr 5, 2013	Inference sec.gov
Tetralogic Pharmaceuticals Corp	Form D equity offering · $5.0M	Clarus Ventures, LLC	strongly supported · board	Dec 13, 2012	Inference sec.gov
Allozyne Inc	Form D equity offering · $2.0M	Clarus Ventures, LLC	strongly supported · board	Jun 1, 2012	Inference sec.gov

Board seats and vehicles

2 boards, 0 vehicles

Allozyne Inc board seat on a deal Apr 5, 2013 Inference
Tetralogic Pharmaceuticals Corp board seat on a deal Dec 13, 2012 Inference

Timeline

6 dated entries: events, attributed deals, board seats and role changes

Mar 24, 2017
Michael Steinmetz (Managing Director) no longer on Schedule A of Clarus Ventures LLC
Person left Inference Clarus Ventures, LLC Form ADV
Mar 24, 2017
Left Clarus Ventures, LLC as Managing Director
Role ended Inference Clarus Ventures, LLC Form ADV
Apr 5, 2013
Form D equity offering in Allozyne Inc (Clarus Ventures, LLC)
Attributed investment Inference Allozyne Inc Form D
Dec 13, 2012
Form D equity offering in Tetralogic Pharmaceuticals Corp (Clarus Ventures, LLC)
Attributed investment Inference Tetralogic Pharmaceuticals Corp Form D
Jun 1, 2012
Form D equity offering in Allozyne Inc (Clarus Ventures, LLC)
Attributed investment Inference Allozyne Inc Form D

Full timeline · 6 entriesnewest first

Mar 24, 2017
Michael Steinmetz (Managing Director) no longer on Schedule A of Clarus Ventures LLC
Person left Inference Clarus Ventures, LLC Form ADV
Mar 24, 2017
Left Clarus Ventures, LLC as Managing Director
Role ended Inference Clarus Ventures, LLC Form ADV
Apr 5, 2013
Form D equity offering in Allozyne Inc (Clarus Ventures, LLC)
Attributed investment Inference Allozyne Inc Form D
Dec 13, 2012
Form D equity offering in Tetralogic Pharmaceuticals Corp (Clarus Ventures, LLC)
Attributed investment Inference Tetralogic Pharmaceuticals Corp Form D
Jun 1, 2012
Form D equity offering in Allozyne Inc (Clarus Ventures, LLC)
Attributed investment Inference Allozyne Inc Form D
Jan 1, 2005
Joined Clarus Ventures, LLC as Managing Director
Role began Inference Clarus Ventures, LLC Form ADV

Record history

1 dated event on the change ledger, latest event first

Person left
2017-03-24source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.